MARZAROLI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 685
EU - Europa 513
AS - Asia 353
SA - Sud America 41
AF - Africa 8
OC - Oceania 4
Totale 1.604
Nazione #
US - Stati Uniti d'America 665
RU - Federazione Russa 315
SG - Singapore 134
IT - Italia 86
CN - Cina 84
VN - Vietnam 39
BR - Brasile 34
HK - Hong Kong 34
DE - Germania 31
GB - Regno Unito 18
FR - Francia 16
IN - India 16
CA - Canada 13
PL - Polonia 8
FI - Finlandia 7
JP - Giappone 7
BD - Bangladesh 6
ID - Indonesia 6
NL - Olanda 6
TR - Turchia 6
ZA - Sudafrica 6
IR - Iran 5
LU - Lussemburgo 5
MX - Messico 5
SE - Svezia 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
AR - Argentina 3
AT - Austria 3
IE - Irlanda 3
IQ - Iraq 3
UA - Ucraina 3
UZ - Uzbekistan 2
BE - Belgio 1
BO - Bolivia 1
CH - Svizzera 1
CO - Colombia 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
ES - Italia 1
ET - Etiopia 1
HN - Honduras 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 1.604
Città #
Dallas 433
Singapore 88
Ashburn 57
Moscow 39
Hong Kong 33
Milan 32
Beijing 26
San Jose 25
New York 16
Munich 14
Ho Chi Minh City 13
Los Angeles 13
Council Bluffs 12
Boardman 10
Hefei 10
Shanghai 9
Frankfurt am Main 8
Hanoi 8
São Paulo 8
Chennai 7
Lauterbourg 7
Naples 7
Orem 7
Warsaw 7
Brooklyn 6
Tokyo 6
Biên Hòa 5
Poplar 5
The Dalles 5
Ankara 4
Atlanta 4
Denver 4
Esch-sur-Alzette 4
London 4
Montreal 4
Nuremberg 4
Santa Clara 4
Turku 4
Vimodrone 4
Arezzo 3
Boston 3
Calgary 3
Da Nang 3
Dublin 3
Gatchina 3
Helsinki 3
Johannesburg 3
Mexico City 3
Paris 3
Turin 3
Appiano Gentile 2
Barnet 2
Binetto 2
Brisbane 2
Chicago 2
Dubai 2
Guangzhou 2
Hyderabad 2
Legnano 2
Manchester 2
Modena 2
Moody 2
Nanjing 2
Ninh Bình 2
Potenza 2
Tashkent 2
Thái Nguyên 2
Toronto 2
Washington 2
Zhangjiagang 2
Abu Dhabi 1
Addis Ababa 1
Al Ain City 1
Almaty 1
Amherstburg 1
Amritsar 1
Amsterdam 1
Araucária 1
Baghdad 1
Bamako 1
Bari 1
Bariri 1
Belmont 1
Bergamo 1
Bitola 1
Bracknell 1
Brescia 1
Brussels 1
Bursa 1
Bắc Ninh 1
Caieiras 1
Calcinate 1
Campestre do Maranhão 1
Campinas 1
Campos Novos 1
Can Tho 1
Capannori 1
Cape Town 1
Castelnuovo Rangone 1
Columbus 1
Totale 1.059
Nome #
Pirfenidone to prevent fibrosis in acute respiratory distress syndrome: The PIONEER study protocol 503
Continuous vs Intermittent Meropenem Administration in Critically Ill Patients With Sepsis: The MERCY Randomized Clinical Trial 156
High dose esomeprazole as an anti-inflammatory agent in sepsis: Protocol for a randomized controlled trial 133
Early noninvasive ventilation in general wards for acute respiratory failure: an international, multicentre, open-label, randomised trial 133
Intravenous amino acids for renal protection in patients receiving temporary mechanical circulatory support: a secondary subgroup analysis of the PROTECTION study 127
A Multinational Randomized Trial of Mega-Dose Esomeprazole As Anti-Inflammatory Agent in Sepsis 124
Continuous infusion versus intermittent administration of meropenem in critically ill patients (MERCY): A multicenter randomized double-blind trial. Rationale and design 119
The role of epinephrine infusion on mortality in critically ill patients A meta-analysis of randomized controlled trials 101
Impact of Cardiopulmonary Bypass Duration on the Renal Effects of Amino Acids Infusion in Cardiac Surgery Patients 100
Correction: Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial (Intensive Care Medicine, (2022), 48, 12, (1736-1750), 10.1007/s00134-022-06912-w) 94
Optimizing meropenem infusion: the importance of concentration and stability 63
Totale 1.653
Categoria #
all - tutte 3.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.939


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223 0 0 0 1 0 0 0 0 0 0 0 2
2022/202311 2 2 0 0 0 1 0 0 1 0 0 5
2023/202463 9 5 8 5 3 7 13 5 0 1 0 7
2024/2025185 8 4 5 11 6 8 14 12 39 18 26 34
2025/20261.390 86 221 299 103 108 50 76 112 297 38 0 0
Totale 1.653